Q4 2022 Holdings
Filed 2023-02-13 | 131 holdings | $204.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $132.0M | 600,000 | 64.5% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $45.8M | 1,000,000 | 22.4% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $5.6M | 500,000 | 2.8% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $4.3M | 1,000,000 | 2.1% |
| Aura Biosciences Inc(AURA) | COM | 05153U107 | $4.3M | 410,000 | 2.1% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $3.0M | 1,646,517 | 1.4% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $2.6M | 250,000 | 1.3% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $1.9M | 250,000 | 0.9% |
| Adagene Inc(ADAG) | ADS | 005329107 | $1.3M | 1,000,000 | 0.6% |
| Cardiff Oncology Inc(CRDF) | COM | 14147L108 | $1.1M | 750,000 | 0.5% |
| Caribou Biosciences Inc(CRBU) | COM | 142038108 | $662.0K | 105,347 | 0.3% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $425.0K | 500,000 | 0.2% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $171.5K | 89,778,234 | 0.1% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $83.0K | 1,832,758 | 0.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $81.3K | 8,980,270 | 0.0% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $59.9K | 1,900,000 | 0.0% |
| Morphic Hldg Inc | COM | 61775R105 | $57.5K | 2,150,000 | 0.0% |
| WW Intl Inc(WW6) | COM | 98262P101 | $57.2K | 14,818,300 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $52.0K | 2,000,000 | 0.0% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $49.9K | 2,000,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $48.8K | 4,000,000 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $46.5K | 900,000 | 0.0% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $41.7K | 2,450,000 | 0.0% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $34.8K | 14,500,000 | 0.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $31.7K | 400,000 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $30.4K | 3,700,000 | 0.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $29.5K | 150,000 | 0.0% |
| Allovir Inc | COM | 019818103 | $28.6K | 5,577,167 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $28.6K | 750,000 | 0.0% |
| Vigil Neuroscience Inc(VIGL) | COM | 92673K108 | $28.0K | 2,243,352 | 0.0% |
| Seer Inc(SEER) | COM CL A | 81578P106 | $27.6K | 4,750,000 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $26.2K | 2,600,000 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $23.8K | 1,000,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR)Call | COM | 60468T105 | $22.7K | 500,000 | 0.0% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $22.2K | 800,000 | 0.0% |
| Beigene LTD(ONC)Call | SPONSORED ADR | 07725L102 | $22.0K | 100,000 | 0.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $21.7K | 1,454,716 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $21.4K | 1,000,000 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $21.1K | 1,700,000 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $21.0K | 3,000,000 | 0.0% |
| Erasca Inc(ERAS) | COM | 29479A108 | $20.3K | 4,710,682 | 0.0% |
| VOR Biopharma Inc | COM | 929033108 | $19.1K | 2,875,581 | 0.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $19.0K | 700,000 | 0.0% |
| Schrodinger Inc(SDGR) | COM | 80810D103 | $13.1K | 700,000 | 0.0% |
| Omega Therapeutics Inc | COM | 68217N105 | $13.0K | 2,273,530 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $12.9K | 2,200,000 | 0.0% |
| KE Hldgs Inc(BEKE)Call | SPONSORED ADS | 482497104 | $11.2K | 800,000 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $11.1K | 500,000 | 0.0% |
| Generation BIO Co(GBIOGBX) | COM | 37148K100 | $11.1K | 2,814,191 | 0.0% |
| Foghorn Therapeutics Inc(FHTX) | COM | 344174107 | $11.0K | 1,720,720 | 0.0% |